US6806652052 - Common Stock

**OLN** gets a fundamental rating of **5** out of 10. The analysis compared the fundamentals against 84 industry peers in the **Chemicals** industry. **OLN** has an average financial health and profitability rating. **OLN** is valued correctly, but it does not seem to be growing.

In multiple years **OLN** reported negative net income over the last 5 years.

Each year in the past 5 years **OLN** had a positive operating cash flow.

The **Return On Equity** of **OLN** (**25.95%**) is better than **89.29%** of its industry peers.

The **Return On Invested Capital** of **OLN** (**12.65%**) is better than **88.10%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 7.73% | ||

ROE | 25.95% | ||

ROIC | 12.65% |

ROA(3y)6.66%

ROA(5y)4.7%

ROE(3y)11.4%

ROE(5y)9.06%

ROIC(3y)N/A

ROIC(5y)N/A

Looking at the **Profit Margin**, with a value of **8.39%**, **OLN** is in the better half of the industry, outperforming **72.62%** of the companies in the same industry.

In the last couple of years the **Operating Margin** of **OLN** has grown nicely.

Looking at the **Gross Margin**, with a value of **19.02%**, **OLN** is doing worse than **66.67%** of the companies in the same industry.

In the last couple of years the **Gross Margin** of **OLN** has grown nicely.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 13.81% | ||

PM (TTM) | 8.39% | ||

GM | 19.02% |

OM growth 3Y66.34%

OM growth 5Y27.61%

PM growth 3YN/A

PM growth 5Y10.05%

GM growth 3Y28.74%

GM growth 5Y15.09%

Compared to 1 year ago, **OLN** has less shares outstanding

Compared to 1 year ago, **OLN** has an improved debt to assets ratio.

The **Altman-Z score** of **OLN** (**2.58**) is better than **65.48%** of its industry peers.

With a decent **Debt to FCF ratio** value of **3.83**, **OLN** is doing good in the industry, outperforming **77.38%** of the companies in the same industry.

Looking at the **Debt to Equity ratio**, with a value of **1.16**, **OLN** is doing worse than **75.00%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.16 | ||

Debt/FCF | 3.83 | ||

Altman-Z | 2.58 |

ROIC/WACC1.44

WACC8.81%

A Current Ratio of **1.50** indicates that **OLN** should not have too much problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.5 | ||

Quick Ratio | 0.8 |

The earnings per share for **OLN** have decreased strongly by **-46.57%** in the last year.

The **Earnings Per Share** has been growing by **60.75%** on average over the past years. This is a very strong growth

Looking at the last year, **OLN** shows a very negative growth in **Revenue**. The Revenue has decreased by **-26.80%** in the last year.

EPS 1Y (TTM)-46.57%

EPS 3Y127.17%

EPS 5Y60.75%

EPS growth Q2Q-57.48%

Revenue 1Y (TTM)-26.8%

Revenue growth 3Y15.34%

Revenue growth 5Y8.39%

Revenue growth Q2Q-28.01%

Based on estimates for the next years, **OLN** will show a decrease in **Revenue**. The Revenue will decrease by **-8.82%** on average per year.

EPS Next Y-58.48%

EPS Next 2Y-33.69%

EPS Next 3Y-13.06%

EPS Next 5YN/A

Revenue Next Year-29.31%

Revenue Next 2Y-14.57%

Revenue Next 3Y-8.82%

Revenue Next 5YN/A

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

A **Price/Earnings** ratio of **10.02** indicates a reasonable valuation of **OLN**.

77.38% of the companies in the same industry are more expensive than **OLN**, based on the **Price/Earnings** ratio.

When comparing the **Price/Earnings** ratio of **OLN** to the average of the S&P500 Index (**24.54**), we can say **OLN** is valued rather cheaply.

A **Price/Forward Earnings** ratio of **12.73** indicates a correct valuation of **OLN**.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 10.02 | ||

Fwd PE | 12.73 |

82.14% of the companies in the same industry are more expensive than **OLN**, based on the **Enterprise Value to EBITDA** ratio.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 8.39 | ||

EV/EBITDA | 5.66 |

PEG (NY)N/A

PEG (5Y)0.16

EPS Next 2Y-33.69%

EPS Next 3Y-13.06%

Compared to an average industry **Dividend Yield** of **3.94**, **OLN** has a dividend in line with its industry peers.

Compared to the average S&P500 **Dividend Yield** of **2.55**, **OLN** is paying slightly less dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.61% |

The dividend of **OLN** has a limited annual growth rate of **0.10%**.

Dividend Growth(5Y)0.1%

Div Incr Years0

Div Non Decr Years20

DP17.12%

EPS Next 2Y-33.69%

EPS Next 3Y-13.06%

**OLIN CORP**

NYSE:OLN (12/11/2023, 3:21:46 PM)

After market: 49.89 0 (0%)**49.89**

**-0.09 (-0.18%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap6.11B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.61% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 10.02 | ||

Fwd PE | 12.73 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)0.16

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 7.73% | ||

ROE | 25.95% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 13.81% | ||

PM (TTM) | 8.39% | ||

GM | 19.02% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.92

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.16 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.5 | ||

Quick Ratio | 0.8 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-46.57%

EPS 3Y127.17%

EPS 5Y

EPS growth Q2Q

EPS Next Y-58.48%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-26.8%

Revenue growth 3Y15.34%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y